Stanniocalcin-2 and insulin-like growth factor-binding protein 4 (IGFBP-4) were shown to be independent predictors of readmission for HF and all-cause death in patients treated with early reperfusion after STEMI [109]. This evidence concerns the gene STC2 and hydrops fetalis.